$TENX

Monday’s insider buys and sells: Coal director invests $3.2M

Insider trading activity reported for US public companies includes significant purchases and sales. ADAR1 Capital bought 1.03M Tenax Therapeutics (TENX) shares for $1.81M. Kenneth Courtis acquired 15K Alpha Metallurgical (AMR) shares for $3.16M. Rex Geveden bought 5K TTM Technologies (TTMI) shares for $524.5K. Ashley McEvoy, CEO of Insulet (PODD), purchased 1.1K shares for $162.2K. Notable sales include James Wirth selling IHT shares for $1.82B, Alexander Karp selling 492K Palantir (PLTR) shares

Original reporting
Published Aug 25, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 1:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$TENX
Bullish
medium confidence
Mentioned
$TENX · $AMR · $TTMI · $BFC · $PODD · $IHT
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$TENXBullishLow
01

Why it matters

Aggregated insider activity provides mixed signals; large sells may pressure stocks while buys could support them.

02

Market read

The filings highlight potential short‑term price moves for the listed tickers.

03

What to watch

Some purchases could be strategic positioning ahead of upcoming corporate events not disclosed yet.

Relevance 4/10Novelty 6/10Timing: Monday

Background

Weekly roundup of Form 4 insider transactions across multiple US‑listed companies.

Company-level read

Ticker impact

$TENXBullishMedium confidence
Context

Form 4 shows insider ADAR1 Capital Management buying $1.81M of Tenax Therapeutics shares.

Expected impact

Potential modest upside as market absorbs buying signal.

Evidence & confidence

Buy amount is sizable for a micro‑cap, but price already down 84% YTD limiting upside.

$AMRBullishMedium confidence
Context

Director Kenneth S. Courtis purchased $3.16M of Alpha Metallurgical Resources shares.

Expected impact

Short‑term price lift expected.

Evidence & confidence

Purchase size relative to float is material; market may view as endorsement.

$TTMIBullishLow confidence
Context

Director Rex D. Geveden bought 5,000 shares of TTM Technologies for $524,500.

Expected impact

Limited upside; may stabilize price.

Evidence & confidence

Purchase is modest relative to market cap.

$BFCNeutralLow confidence
Context

Director Tracy C Pearson acquired 1,024 shares of Bank First Corp for $160,737.

Expected impact

Minimal impact.

Evidence & confidence

Transaction size is tiny relative to float.

$PODDBullishMedium confidence
Context

CEO Ashley McEvoy bought 1,100 shares of Insulet Corp for $162,217.

Expected impact

Potential modest rally if market interprets as confidence.

Evidence & confidence

Executive buying is a strong signal, though amount is modest.

$IHTBearishMedium confidence
Context

CEO James F. Wirth sold 34,800 shares of Innsuites Hospitality Trust worth $1.82B.

Expected impact

Downward pressure likely.

Evidence & confidence

Sale size is massive relative to market cap.

$CHYMBearishMedium confidence
Context

DST Global Advisors sold $28.1M of Chime Financial shares.

Expected impact

Potential short‑term dip.

Evidence & confidence

Sale amount is notable for a fintech of this size.

$PLTRBearishMedium confidence
Context

CEO Alexander C. Karp sold 492,348 shares of Palantir for $86.06M.

Expected impact

Possible modest decline.

Evidence & confidence

Size is material; tax‑driven sales still signal liquidity need.

Market effects

Insider activity across healthcare, fintech, mining, and REITs may influence sector sentiment.

US market focus; no notable regional spillover.

Limited to US‑listed equities.

Counterpoint

Insider sells may be routine tax planning rather than lack of confidence.

Key entities

  • Tenax Therapeutics

    Biotech micro‑cap with recent insider buying.

  • Palantir Technologies

    Data‑analytics firm with large insider sell.

Related articles

$PLTRHigh

Dan Ives Draws a Sharp Line Between Two AI Stock Giants

Dan Ives initiated Palantir (PLTR) with a Buy rating and $250 target, citing 93% YoY revenue growth and strong AI adoption. Oracle (ORCL) received a Hold rating and $155 target due to capital-intensive AI investments and negative free cash flow. Palantir's growth is high-margin, while Oracle's cloud infrastructure demands significant financing.

$SOXLMed

Korean Retail Investors Dump Semiconductor Leverage ETFs, Rotate Into Ultra-Short Treasuries and Dividend Funds

South Korean retail investors sold $1.1B in semiconductor 3x leveraged ETFs, notably SOXL, and shifted to ultra-short Treasuries and dividend ETFs like SCHD and JEPQ. Concerns over rising interest rates and AI investment slowdown drove the shift. SOXS saw $138.83M in net buying, while individual semiconductor stocks like SK Hynix and Nvidia also faced net selling.

$PLTRMed

Government Contract Update: $92M payment to PALANTIR USG INC

Palantir (PLTR) received a $92M payment from the Department of Defense on 2026-06-30, according to USASpending.gov. The company has received $2.05B in government contracts over the past year. Additionally, insiders and members of Congress have recently traded PLTR stock, with notable sales by insiders and mixed trades by Congress members. Hedge funds have also shown significant activity, with some increasing their positions while others decreased.

Med

Stafford's TTM Technologies Awarded Additional Defense Contract

TTM Technologies received 6% of a $511M contract for Navy's SPY-6 radar systems, following a similar $1.809B contract in July. The company employs about 1,000 people in Connecticut, producing electronic systems for aerospace and defense. Rep. Joe Courtney highlighted the contract as a sign of the region's defense manufacturing growth.